欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/1963/004
药品名称
Qsiva
活性成分
Phentermine hydrochloride 15.0 mg
Topiramate 92.0 mg
剂型
Modified-release capsule, hard
上市许可持有人
Vivus BV
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Lithuania (LT)
Qsiva 15 mg/92 mg modifikuoto atpalaidavimo kietosios kapsulės
Hungary (HU)
Qsiva 3.75 mg/23 mg - 7.5 mg/46 mg - 11.25 mg/69 mg - 15 mg/92 mg módosított hatóanyagleadású kemény kapszula
Czechia (CZ)
Qsiva
Romania (RO)
Slovakia (SK)
Denmark (DK)
Slovenia (SI)
Iceland (IS)
Qsiva
Croatia (HR)
Norway (NO)
Qsiva
Ireland (IE)
Malta (MT)
Finland (FI)
Portugal (PT)
Poland (PL)
Greece (GR)
许可日期
2020/12/22
最近更新日期
2024/11/28
药物ATC编码
A08AA01 phentermine
N03AX11 topiramate
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Multiple (Copy) Application
TypeLevel3:
Full Dossier Art 8.3(i) Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE_H_1963_004_Final PL
Date of last change:2024/09/06
Final SPC
|
SE_H_1963_004_Final SPC
Date of last change:2024/09/06
PubAR
|
SE_H_1963_004_PAR
Date of last change:2024/09/06
PubAR Summary
|
SE_H_1963_004_PAR Summary
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase